• No results found

18 results with keyword: 'novel target tumor suppressor implication clear renal carcinoma'

ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma

Although we could not test the effect of ERK5 interference in a xenograft model of 769-P cells due to the low tumorigenicity of the cell lines (Figure W5), we explored ERK5

Protected

N/A

15
0
0
2021
ERK5/BMK1 is a novel target of the tumor suppressor VHL: Implication in clear cell renal carcinoma

Although we could not test the effect of ERK5 interference in a xenograft model of 769-P cells due to the low tumorigenicity of the cell lines (Figure W5), we explored ERK5

Protected

N/A

15
0
0
2021
Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma

Reactivation of PAX2 has been frequently observed in clear cell renal cell carcinoma (ccRCC), a tumor type characterized by loss of von Hippel-Lindau (VHL) tumor suppressor

Protected

N/A

10
0
0
2021
Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors

Consistent with a potential role for SOSTDC1 as a tumor suppressor, SOSTDC1 expression was statisti- cally significantly decreased in both adult clear cell renal carcinoma and

Protected

N/A

9
0
0
2020
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is characterized by loss of the tumor suppressor von Hippel-Lindau ( VHL ) and altered cancer cell metabolism.. Here, we assessed how

Protected

N/A

14
0
0
2020
Alpin D. Malkan, MD Senior Fellow, St. Jude Children s Research Hospital Le Bonheur Children s Hospital Grand Rounds January 14, 2015

Renal lesions in children Malignant Wilms tumor Clear Cell Sarcoma Renal Cell Carcinoma Clear cell Medullary carcinoma Multicystic Chromophil Chromophobe Collecting duct

Protected

N/A

108
0
0
2021
The Impact of Tumor Eco-Evolution in Renal Cell Carcinoma Sampling

Keywords: clear cell renal cell carcinoma; tumor evolution; tumor ecology; intratumor heterogeneity; multisite tumor sampling; targeted

Protected

N/A

10
0
0
2021
Administrative Decentralization and Tax Compliance: A Transactional Cost Perspective

Decentralization is thus a kind of determinant of administrative practice that is more amenable to change than those (such as the informal economy and the state of development of

Protected

N/A

61
0
0
2021
Rodney Coe, MD, MS SUNY Downstate Medical Center December 3, 2009

Multifocal choroiditis with panuveitis: Incidence of ocular complications and loss of visual acuity.. Intravitreal injection of

Protected

N/A

37
0
0
2021
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma

FSTL1: follistatin-like protein 1; RCC: renal cell carcinoma; ccRCC: clear cell RCC; HIF: hypoxia-inducible factor; IκBα: inhibitor of NF-κB; CXCR8: chemokine (C-X-C motif )

Protected

N/A

15
0
0
2020
Two single nucleotide polymorphisms in the von Hippel Lindau tumor suppressor gene in Taiwanese with renal cell carcinoma

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Yang K, Lindblad P, Egevad L, Hemminki K: Novel somatic

Protected

N/A

8
0
0
2020
Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma

In vitro promoter methylation analysis using human neuroblastoma (SH-SY5Y) and immortalized kidney cells (IHKE) revealed that total promoter methylation by CpG methyltransferase Sss

Protected

N/A

10
0
0
2020
Summary of cardiovascular health among Aboriginal and Torres Strait Islander people

This program aims to improve the care Aboriginal and Torres Strait Islander people receive after a stroke or brain injury, improve the health of Aboriginal and Torres Strait

Protected

N/A

30
0
0
2021
von Hippel-Lindau disease: An Update

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.. Hum Mol

Protected

N/A

18
0
0
2021
Clear Cell Papillary Renal Cell Carcinoma and Renal Angiomyoadenomatous Tumor: Two Variants of a Morphologic, Immunohistochemical, and Genetic Distinct Entity of Renal Cell Carcinoma

Abstract: Clear cell papillary renal cell carcinoma (ccpRCC) and renal angiomyoadenomatous tumor (RAT) share morphologic similarities with clear cell (ccRCC) and papillary RCC

Protected

N/A

14
0
0
2021
Perivascular epithelial cell tumor (PEComa) of the pancreas: a case report and review of previous literatures

Differential diagnoses of pancreatic PEComa were included epithelial tumors such as primary clear cell carcinoma, metastatic renal cell carcinoma, endocrine tumor with clear

Protected

N/A

7
0
0
2020
Case Report Uretheral invagination of multilocular cystic nephroma; a case report of a new pathologic variant

This tumor is confused with cystic partially differentiated nephroblastoma and cystic Wilms tumor in childhood, and multilocular cystic renal cell carcinoma, clear cell papillary

Protected

N/A

9
0
0
2020
Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma

Abbreviations RCC: renal cell carcinoma; ccRCC: clear cell renal cell carcinoma; TIICs: tumor-infiltrating immune cells; ECM: extracellular matrix; TCGA: The Cancer Genome Atlas;

Protected

N/A

15
0
0
2022

Upload more documents and download any material studies right away!